Phase 2 Study of TLK286 in Metastatic Breast Cancer

Akt Inhibitor MK2206 in Treating Patients With Advanced Breast Cancer

NCT01277757 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer

NCT00313248 ·Status: COMPLETED ·Phase: PHASE2

A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Participants With Locally Recurrent or Metastatic Breast Cancer

NCT01740336 ·Status: COMPLETED ·Phase: PHASE2

Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer

NCT00002873 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival

NCT02364557 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients

NCT01625286 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Talimogene Laherparepvec in Treating Patients With Recurrent Breast Cancer That Cannot Be Removed by Surgery

NCT02658812 ·Status: TERMINATED ·Phase: PHASE2

Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer

NCT05826964 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

ZK 230211 in Postmenopausal Woman With Metastatic Breast Cancer

NCT00555919 ·Status: COMPLETED ·Phase: PHASE2

Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery

NCT00305825 ·Status: COMPLETED ·Phase: PHASE2

MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer

NCT01319539 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Participants With Human Epidermal Growth Factor-2 (HER2) Positive Locally Advanced or Metastatic Breast Cancer (BC) Who Received Prior Trastuzumab and Taxane Based Therapy

NCT02924883 ·Status: COMPLETED ·Phase: PHASE2

A Study to Learn About the Safety of TALZENNA for the Treatment of Breast Cancer

NCT06735742 ·Status: ACTIVE_NOT_RECRUITING

Abraxane in Treatment of Metastatic Breast Cancer

NCT02555696 ·Status: COMPLETED

To Identify Primary Resistance to CDK4/6 Inhibitors in Breast Cancer

NCT04660435 ·Status: RECRUITING

S0029 Docetaxel in Treating Older Women With Metastatic Breast Cancer

NCT00025493 ·Status: TERMINATED ·Phase: PHASE2

Doxorubicin in Treating Women With Advanced Breast Cancer

NCT00003165 ·Status: UNKNOWN ·Phase: PHASE2

A Trial of Oral BEZ235 and BKM120 in Combination With Paclitaxel With or Without Trastuzumab

NCT01285466 ·Status: COMPLETED ·Phase: PHASE1

Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer

NCT00364611 ·Status: COMPLETED ·Phase: PHASE2

R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy

NCT00028873 ·Status: COMPLETED ·Phase: PHASE2

Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic Response

NCT02280252 ·Status: COMPLETED ·Phase: PHASE2

To Reverse ENDocrine Resistance Trial - PD 0332991 Monotherapy vs PD 0332991 in Combination With the Endocrine Therapy

NCT02549430 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer

NCT03125928 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Determine the Antitumor Activity and Evaluate the Safety of MKC-1

NCT00306631 ·Status: COMPLETED ·Phase: PHASE2

Study of MDX-010 in Stage IV Breast Cancer

NCT00083278 ·Status: COMPLETED ·Phase: PHASE2